Suppliers / Hisun Pharmaceutical (Hangzhou)

Hisun Pharmaceutical (Hangzhou)

China Updated 9 July 2026

The public registers hold a second record for Hisun Pharmaceutical (Hangzhou). The fuller profile, with 0 active US DMFs and 22 valid CEPs, is at Hisun Pharmaceutical. Figures on this page cover only this record.

Hisun Pharmaceutical (Hangzhou) is an API manufacturer based in China. It holds 4 valid CEPs across a filed portfolio of 4 molecules.

0
active US DMFs
4
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Hangzhou City, China Not on file

What they file, and where

Molecule Regulators Docs
Everolimus EDQM 1
Moxidectin For Veterinary Use EDQM 1
Mycophenolate Mofetil EDQM 1
Tacrolimus EDQM 1

Also appears on these molecule pages

Everolimus API Mycophenolate Mofetil API Tacrolimus API

Questions about Hisun Pharmaceutical (Hangzhou)

Does Hisun Pharmaceutical (Hangzhou) hold a US DMF or a CEP?
Hisun Pharmaceutical (Hangzhou) holds 4 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Hisun Pharmaceutical (Hangzhou) manufacture?
1 registered site is on record, in China (Hangzhou City). Every site is listed on this page with the register it came from.
What does Hisun Pharmaceutical (Hangzhou) make?
4 molecules are on record against Hisun Pharmaceutical (Hangzhou), including Everolimus, Moxidectin For Veterinary Use, Mycophenolate Mofetil and Tacrolimus. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Hisun Pharmaceutical (Hangzhou)?

Ask Fred what the record holds on Hisun Pharmaceutical (Hangzhou), including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Biocon shares 3 molecules Concord Biotech shares 3 molecules Chunghwa Chemical Synthesis & Biotech shares 3 molecules Apotex shares 2 molecules Lek Pharmaceuticals shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability